www.fdanews.com/articles/113569-plexxikon-roche-sign-deal-to-develop-commercialize-kinase-inhibitor

Plexxikon, Roche Sign Deal to Develop, Commercialize Kinase Inhibitor

January 8, 2009

Plexxikon Inc. and Roche jointly announced that they have entered into an agreement to develop and commercialize a second novel kinase inhibitor, PLX5568.
RTTNews